Comparative solution equilibrium studies of antitumor ruthenium(η6-p-cymene) and rhodium(η5-C5Me5) complexes of 8-hydroxyquinolines-Reference-Cited by-同舟云学术

Comparative solution equilibrium studies of antitumor ruthenium(η6-p-cymene) and rhodium(η5-C5Me5) complexes of 8-hydroxyquinolines

Published:2017 Issue:13 Volume:46 Page:4382-4396
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Dömötör Orsolya¹²³⁴⁵,Pape Veronika F. S.⁶⁷⁸⁹⁴,May Nóra V.¹⁰⁹⁴,Szakács Gergely⁶⁷⁸⁹⁴,Enyedy Éva A.¹²³⁴^ORCID

Affiliation:

1. Department of Inorganic and Analytical Chemistry

2. University of Szeged

3. H-6720 Szeged

4. Hungary

5. MTA-SZTE Bioinorganic Chemistry Research Group

6. Institute of Enzymology

7. Research Centre for Natural Sciences

8. Hungarian Academy of Sciences

9. H-1117 Budapest

10. Research Centre for Natural Sciences Hungarian Academy of Sciences

Abstract

Solution stability, chloride ion affinity and multidrug resistance selectivity of half-sandwich Rh(η⁵-C₅Me₅) and Ru(η⁶-p-cymene) complexes of 8-hydroxyquinolines.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/DT/C7DT00439G

Reference58 articles.

1. NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

2. KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

3. Ruthenium Antimetastatic Agents

4. Thirty Years of the Drug Candidate NAMI‐A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective

5. Recent advances in supramolecular and biological aspects of arene ruthenium(II) complexes

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruthenium-p-Cymene Complexes Incorporating Substituted Pyridine–Quinoline Ligands with –Br (Br-Qpy) and –Phenoxy (OH-Ph-Qpy) Groups for Cytotoxicity and Catalytic Transfer Hydrogenation Studies: Synthesis and Characterization;Chemistry;2024-08-21

2. Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine–Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties;Molecules;2024-07-06

3. Complex formation of ML324, the histone demethylase inhibitor, with essential metal ions: Relationship between solution chemistry and anticancer activity;Journal of Inorganic Biochemistry;2024-06

4. Synthesis and characterization of new iridium(III) complexes containing the fragment [Cp*IrCl ₂ ] and the ligands 2- and 4-aminobenzonitryl and 2- and 4-aminopyridine;Journal of Coordination Chemistry;2024-03-03

5. Potent Half-Sandwich 16-/18-Electron Iridium(III) and Ruthenium(II) Anticancer Complexes with Readily Available Amine–Imine Ligands;Inorganic Chemistry;2023-12-14